latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
TheStreet.com
Tue, 05/21/13 - 12:05 pm
tags: Adcetris, Amag Pharmaceuticals, Amarin, Antares, Auxilium, Aveo Pharmaceuticals, Cubist Pharmaceuticals, dabrafenib, Delcath, Depomed, Dolutegravir, drug approvals, efinaconazole, Entereg, Feraheme, Gilead, GSK, Melblez, Merck, Otrexup, Seattle Genetics, Sefelsa, sofosbuvir, suvorexant, tivozanib, Trametenib, Valeant Pharmaceuticals, Vascepa, Xiaflex, Zogenix, Zohydro
Seeking Alpha
Mon, 05/20/13 - 5:26 pm
tags: Bristol-Myers Squibb, cancer, lambrolizumab, lung cancer, melanoma, Merck, nivolumab, PD-L1, Roche
Motley Fool
Sat, 05/18/13 - 12:12 pm
Forbes
Thu, 05/16/13 - 11:07 am
tags: Bristol-Myers Squibb, Merck, nivolumab, Ono Pharmaceuticals, Roche, Yervoy
Fierce Pharma
Wed, 05/15/13 - 9:28 am
Motley Fool
Wed, 05/15/13 - 9:06 am
tags: Gilead, hepatitis C, JNJ, Merck, Roche, Vertex Pharmaceuticals
Seeking Alpha
Tue, 05/14/13 - 9:13 am
Motley Fool
Sun, 05/12/13 - 11:10 am
Motley Fool
Sun, 05/12/13 - 11:04 am
Yahoo/YCharts
Fri, 05/10/13 - 12:35 pm
Motley Fool
Fri, 05/10/13 - 8:58 am
Bloomberg
Thu, 05/09/13 - 8:26 am
Forbes
Tue, 05/07/13 - 11:31 am
tags: Alkermes, AstraZeneca, clinical depression, Lundbeck, Merck, Novartis, Pfizer, Sanofi
Last 30 twitter posts
-
Tue May 21, 2013 10:33pm EDT. (Reuters) - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldma..
-
Tue May 21, 2013 10:33pm EDT. (Reuters) - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldma..
-
By Toni Clarke. WASHINGTON | Mon May 20, 2013 12:07pm EDT. WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug suvorexant ..
-
RT @asxacl: New company update covering fondaparinux, collaboration with Merck Serono SA and HA-Irinotecan Phase III trial t.co/mYbAJmU97o
-
Roche BristolMyers Merck drugs aim at lung cancer - A new class of experimental drugs shown to shrink tumors by un... t.co/oFQLugcqzs
-
Merck Announces $5 Billion Accelerated Share Repurchase - Merck NYSE MRK known as MSD outside the United States an... t.co/bybbScPLqE
-
Merck signs $5 billion share buyback agreement with Goldman Sachs t.co/LxQAzujYcM
-
Merck signs $5 billion share buyback agreement with Goldman Sachs t.co/aC3fc0yBu0
-
BizzNews: Merck signs $5 billion share buyback agreement with Goldman Sachs t.co/PZHANkXuso
-
MedIndustry: Merck signs $5 bln share buyback agreement with Goldman Sachs t.co/emtt74bUfu
-
New Business Blog: Merck signs $5 billion share buyback agreement with Goldman Sachs t.co/E6EpOALQXI #business #webdesign #webhost
-
t.co/wNd7Q4c5ta Merck signs $5 billion share buyback agreement with Goldman Sachs t.co/kgwjWZm3dC
-
Merck signs $5 billion share buyback agreement with Goldman Sachs (Reuters) t.co/hNt4pPF6FF t.co/twosmOYDmC
-
Tue May 21, 2013 10:33pm EDT. (Reuters) - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldma..
-
I'm at Merck Sharp & Dohme (İstanbul) t.co/LXp2G4kWkF
-
RT @MedicalNews: Merck signs $5 billion share buyback agreement with Goldman Sachs t.co/0XRlrc6bNa
-
By Toni Clarke. WASHINGTON | Mon May 20, 2013 12:07pm EDT. WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug suvorexant ..
-
Roche BristolMyers Merck drugs aim at lung cancer: A new class of experimental drugs shown to shrink tumors by... t.co/d6s6y6uwqy
-
Tue May 21, 2013 10:33pm EDT. (Reuters) - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldma..
-
RT @MedicalNews: Merck signs $5 billion share buyback agreement with Goldman Sachs t.co/0XRlrc6bNa
-
Merck signs $5 billion share buyback agreement with Goldman Sachs: (Reuters) - Merck & Co Inc said it has ente... t.co/2FPgD9wFli
-
RT @ReutersBiz: Merck signs $5 billion share buyback agreement with Goldman Sachs t.co/iacVpN4eam
-
Sinu-sino na pong Overheard Admins ang na-meet niyo n... — Wala pa actually. Pero nakita ko na si Merck dati sa ... t.co/5YYuhRYINb
-
Merck signs $5 bln share buyback agreement with Goldman Sachs t.co/Law4ZasZFl
-
Merck signs $5 billion share buyback agreement with Goldman Sachs t.co/0XRlrc6bNa
-
Merck signs $5 billion share buyback agreement with Goldman Sachs t.co/26hDvL62gO
-
By Toni Clarke. WASHINGTON | Mon May 20, 2013 12:07pm EDT. WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug suvorexant ..
-
Merck signs $5 billion share buyback agreement with Goldman Sachs: (Reuters) - Merck & Co Inc said it has entered... t.co/8qAOzVBGo1
-
Merck signs $5 billion share buyback agreement with Goldman Sachs t.co/GPK0g3SWjl
-
[KC Star: Business] Merck to repurchase $5B in common stock t.co/Z4yvAOlk1L
Latest Health Message Board Posts
... things we learned in Nursing was never try to diagnose ourselves we would all be "dying " in a week after getting our new Merck textbook! ! Lol I know it's scary to have undiagnosed problems but as Barbara told you many many things effect sediment rate ...
Posted by:
nvrthesame98
at
2013-05-20 12:49:00
on
healingwell.com
All I know is its a silk tube? I dont know who its made by but its says 'corflo/merck' on it, dont have a clue what that means but thought id say it! lol its not that bad, before this tube I had a plastic one as ...
Posted by:
purplecat
at
2013-05-19 05:00:00
on
medhelp.org
Hello there, I am on new medications now cause I was not doing good on Euthyrox and still have 425 X Euthyrox 50 (Merck, Germany) left. I'm sorry, but I had to delete your contact information. It is illegal in the US (where this forum is based) to share ...
Posted by:
Tuelay
at
2013-05-15 16:01:00
on
healingwell.com
... week blood draws in a trial I am in. No sides so far, but I am only in one week. First off..... I remembered wrong. The Vertex/Merck NDA's took about 6 months to approval, not longer; big holidays included. Apologies. Whether these approvals take 4 months ...
Posted by:
hrsepwrguy
at
2013-05-14 05:00:00
on
medhelp.org
Hi here is some information on Victrellis and treatment length, I hope this can help you http://www.merck.com/product/usa/pi_circulars/v/victrelis/victrelis_pi.pdf
Posted by:
Dr Santos
at
2013-05-01 05:00:00
on
medhelp.org
... than the rate of SVR for truncating treatment. I will see if I can find that link. It might be in this: http://www.merck.com/product/usa/pi_circulars/v/victrelis/victrelis_pi.pdf I hope you find a way to hang in there. We do not really know when the all ...
Posted by:
jonkob
at
2013-05-01 05:00:00
on
medhelp.org
Hi, How are you? Cirrhosis may be asymptomatic or with few symptoms and signs of liver disease. Some of the symptoms may also be nonspecific and may not suggest that the liver is their cause. This may be what it meant. Aside from symptomatology, clinical ...
Posted by:
Idyllic
at
2013-04-27 05:00:00
on
medhelp.org
I have red palms and have had pale fingernails for 30 years, I'm not cirrhotic (hopefully) I think there has to be concrete findings via labs and imaging tests. Cirrhosis or any other disease can't be diagnosed based on secondary symptoms. Just my opinion.
Posted by:
Ki3
at
2013-04-26 10:43:00
on
chronsforum.com
"Am I getting the wrong info?" That depends on which makers prescribing info you look at, rebatol (merck) says 800 for your wt, copegus (genetech) says 1000
Posted by:
Dee1956
at
2013-04-25 05:00:00
on
medhelp.org
... 12 week Naive geno 1 was announced 03May but I have not seen this one posted on clinical trials. I started with Gilead. Abbot, Merck. Bristol Myers are also doing PI trials no interferon. From what I read of your posts you are looking in the right places ...
Posted by:
Willy50
at
2013-04-24 05:00:00
on
medhelp.org